Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Fenghuang Zhan

Concepts (592)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
139
2025
3049
10.260
Why?
Gene Expression Regulation, Neoplastic
53
2025
857
3.200
Why?
Drug Resistance, Neoplasm
25
2020
326
3.050
Why?
Plasma Cells
24
2025
239
2.940
Why?
Gene Expression Profiling
44
2025
1105
2.810
Why?
Monoclonal Gammopathy of Undetermined Significance
9
2025
125
2.690
Why?
Cell Proliferation
25
2022
1023
2.130
Why?
Antineoplastic Agents
29
2020
1222
2.030
Why?
Cell Line, Tumor
46
2025
1470
1.890
Why?
Neoplastic Stem Cells
7
2020
99
1.620
Why?
Pyrazines
19
2023
190
1.520
Why?
Disease Progression
19
2025
871
1.520
Why?
Mice
48
2025
5949
1.400
Why?
Paraproteinemias
9
2024
74
1.390
Why?
Humans
161
2025
52483
1.380
Why?
Lymphoma, B-Cell
5
2021
61
1.370
Why?
Apoptosis
18
2025
1119
1.360
Why?
Prognosis
39
2025
2099
1.320
Why?
Boronic Acids
17
2014
183
1.320
Why?
Bone Resorption
6
2024
302
1.320
Why?
Animals
59
2025
13505
1.210
Why?
Tumor Microenvironment
6
2024
256
1.200
Why?
Neoplasm Proteins
7
2021
334
1.140
Why?
Osteolysis
4
2022
75
1.080
Why?
B-Lymphocytes
8
2021
184
1.040
Why?
Cell Cycle Proteins
4
2023
169
1.000
Why?
T-Lymphocytes
8
2024
340
0.960
Why?
Hematopoietic Stem Cell Transplantation
6
2024
603
0.940
Why?
Ubiquitination
3
2021
47
0.910
Why?
Proteasome Inhibitors
7
2020
104
0.890
Why?
Signal Transduction
21
2023
1671
0.850
Why?
Proteasome Endopeptidase Complex
4
2018
117
0.800
Why?
MicroRNAs
7
2022
387
0.780
Why?
Antigens, CD
8
2024
218
0.740
Why?
Neoplasms
3
2024
1325
0.710
Why?
Iron
3
2017
127
0.690
Why?
Ascorbic Acid
2
2017
25
0.680
Why?
Carrier Proteins
3
2017
313
0.650
Why?
CDC2-CDC28 Kinases
3
2015
11
0.640
Why?
Cation Transport Proteins
2
2019
27
0.630
Why?
Chromosome Aberrations
7
2025
297
0.630
Why?
Up-Regulation
6
2020
454
0.610
Why?
Ubiquitins
2
2016
40
0.610
Why?
Cyclin-Dependent Kinases
2
2010
26
0.600
Why?
Mice, Inbred NOD
5
2020
92
0.600
Why?
Oligonucleotide Array Sequence Analysis
19
2014
405
0.600
Why?
Glycolysis
3
2022
73
0.600
Why?
Waldenstrom Macroglobulinemia
1
2018
40
0.590
Why?
Cell Survival
11
2020
612
0.580
Why?
Cell Differentiation
9
2023
665
0.570
Why?
Proto-Oncogene Proteins c-akt
5
2023
169
0.570
Why?
Pyrimidines
3
2015
199
0.560
Why?
STAT3 Transcription Factor
4
2016
85
0.550
Why?
Killer Cells, Natural
5
2024
116
0.540
Why?
Pyruvate Kinase
1
2017
7
0.540
Why?
Antineoplastic Combined Chemotherapy Protocols
10
2024
1031
0.530
Why?
RNA Splicing
1
2017
41
0.530
Why?
Female
46
2025
28171
0.500
Why?
Protein-Tyrosine Kinases
2
2015
87
0.500
Why?
Down-Regulation
9
2019
346
0.490
Why?
Cyclopentanes
1
2015
12
0.490
Why?
Male
36
2025
26761
0.480
Why?
Transplantation, Autologous
5
2024
488
0.480
Why?
Thalidomide
10
2023
377
0.480
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2015
68
0.480
Why?
Aldehyde Dehydrogenase
1
2014
25
0.470
Why?
Osteoclasts
7
2023
428
0.460
Why?
Dexamethasone
7
2024
438
0.450
Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2020
17
0.450
Why?
Models, Biological
5
2018
735
0.420
Why?
Receptors, Retinoic Acid
2
2013
22
0.420
Why?
Hematologic Neoplasms
1
2015
106
0.420
Why?
Cystatin M
2
2024
19
0.420
Why?
RNA, Messenger
13
2021
1132
0.410
Why?
Flow Cytometry
8
2018
478
0.400
Why?
B-Cell Maturation Antigen
2
2024
98
0.400
Why?
Antigens, Neoplasm
6
2014
147
0.400
Why?
Mice, Transgenic
7
2021
552
0.400
Why?
Glucuronidase
4
2018
47
0.390
Why?
Aged
26
2025
10121
0.390
Why?
Predictive Value of Tests
5
2016
944
0.370
Why?
Antibodies, Bispecific
2
2023
94
0.360
Why?
Syndecan-1
6
2017
74
0.360
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
6
0.360
Why?
Arsenicals
1
2010
15
0.350
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
20
0.350
Why?
Oxides
1
2010
21
0.350
Why?
Reverse Transcriptase Polymerase Chain Reaction
12
2015
582
0.340
Why?
Janus Kinase 1
1
2010
16
0.340
Why?
Proto-Oncogene Proteins c-jun
2
2009
75
0.340
Why?
MAP Kinase Kinase 1
1
2010
23
0.340
Why?
Middle Aged
25
2025
13028
0.330
Why?
DNA-Binding Proteins
4
2021
422
0.330
Why?
Immunotherapy, Adoptive
2
2024
166
0.330
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
82
0.330
Why?
Early Growth Response Protein 1
1
2009
34
0.320
Why?
Transcription Factors
6
2022
566
0.320
Why?
Lymphoma, Large B-Cell, Diffuse
2
2024
106
0.310
Why?
Tretinoin
1
2009
54
0.310
Why?
Oligopeptides
3
2015
92
0.310
Why?
Membrane Proteins
4
2018
335
0.300
Why?
Xenograft Model Antitumor Assays
7
2019
220
0.300
Why?
Osteogenesis
5
2023
366
0.300
Why?
NF-kappa B
3
2018
322
0.300
Why?
Genes, Neoplasm
1
2008
31
0.290
Why?
Tumor Cells, Cultured
6
2020
460
0.290
Why?
Antibodies
3
2024
159
0.290
Why?
Microarray Analysis
3
2018
71
0.280
Why?
Adult
22
2025
14161
0.280
Why?
Chromosomes, Human, Pair 1
4
2023
96
0.280
Why?
Oxidative Stress
5
2017
807
0.280
Why?
Immunologic Factors
5
2015
117
0.270
Why?
S-Phase Kinase-Associated Proteins
1
2007
2
0.270
Why?
Interleukin-6
3
2019
278
0.270
Why?
Neoplasms, Plasma Cell
2
2023
37
0.270
Why?
Retrospective Studies
8
2025
6607
0.270
Why?
Tumor Suppressor Protein p53
2
2008
221
0.270
Why?
Small Molecule Libraries
2
2019
67
0.270
Why?
Pyrazoles
2
2020
114
0.260
Why?
Aged, 80 and over
8
2025
3392
0.260
Why?
Mice, SCID
9
2018
182
0.250
Why?
CD8-Positive T-Lymphocytes
3
2024
132
0.250
Why?
Endopeptidase Clp
1
2025
2
0.240
Why?
Protein Kinase Inhibitors
3
2024
227
0.240
Why?
Genomics
2
2023
268
0.240
Why?
Risk Factors
11
2018
3889
0.240
Why?
Survival Rate
8
2020
945
0.230
Why?
Enzyme Inhibitors
4
2019
372
0.230
Why?
Bone Diseases
4
2016
96
0.230
Why?
Bone Marrow
7
2024
364
0.230
Why?
Polycomb Repressive Complex 2
2
2021
48
0.230
Why?
ROC Curve
1
2025
253
0.230
Why?
Diffusion Magnetic Resonance Imaging
1
2025
133
0.230
Why?
Single-Cell Analysis
1
2025
81
0.220
Why?
Receptors, LDL
1
2024
71
0.220
Why?
Transcriptome
2
2025
370
0.220
Why?
Propionates
1
2024
24
0.220
Why?
Hydroxybenzoates
1
2024
24
0.220
Why?
TNF Receptor-Associated Factor 3
2
2022
13
0.220
Why?
Ferritins
1
2024
36
0.220
Why?
Myeloid Progenitor Cells
1
2023
17
0.220
Why?
X-Ray Microtomography
1
2024
79
0.220
Why?
Histocompatibility Antigens Class I
2
2015
48
0.210
Why?
Melphalan
3
2023
181
0.210
Why?
Cholesterol
1
2024
153
0.210
Why?
Antigens, CD19
3
2018
28
0.210
Why?
Bone Marrow Cells
4
2015
190
0.210
Why?
Neoplasms, Second Primary
1
2024
77
0.210
Why?
Proteolysis
4
2018
101
0.210
Why?
Membrane Glycoproteins
6
2009
244
0.210
Why?
Positron-Emission Tomography
1
2025
301
0.210
Why?
Cell Transformation, Neoplastic
1
2024
184
0.210
Why?
Genes, myc
3
2019
39
0.210
Why?
Intercellular Signaling Peptides and Proteins
4
2007
105
0.210
Why?
Proto-Oncogene Proteins c-myc
3
2025
53
0.210
Why?
Lymphoma
1
2024
71
0.210
Why?
Bone Diseases, Metabolic
1
2024
78
0.210
Why?
Colonic Neoplasms
2
2022
163
0.210
Why?
Homeostasis
1
2024
201
0.210
Why?
Cluster Analysis
5
2009
233
0.200
Why?
Gene Knockdown Techniques
3
2018
108
0.200
Why?
Phenols
1
2024
92
0.200
Why?
Bone and Bones
2
2021
494
0.200
Why?
NM23 Nucleoside Diphosphate Kinases
1
2022
4
0.200
Why?
Protein Binding
2
2018
667
0.200
Why?
Neutropenia
1
2023
115
0.200
Why?
Recurrence
7
2018
672
0.200
Why?
Periodontitis
1
2022
11
0.200
Why?
Randomized Controlled Trials as Topic
6
2016
595
0.200
Why?
Antibodies, Monoclonal
3
2013
481
0.190
Why?
In Situ Hybridization, Fluorescence
5
2023
263
0.190
Why?
Case-Control Studies
8
2020
1201
0.190
Why?
Reactive Oxygen Species
4
2017
421
0.190
Why?
Carcinoma, Non-Small-Cell Lung
1
2024
170
0.190
Why?
Protein Stability
2
2020
45
0.190
Why?
Osteoporosis
1
2023
162
0.190
Why?
Kaplan-Meier Estimate
5
2016
483
0.190
Why?
Arthritis, Rheumatoid
1
2022
116
0.180
Why?
Mitochondria
1
2025
430
0.180
Why?
Heterogeneous-Nuclear Ribonucleoprotein Group A-B
1
2021
1
0.180
Why?
Nuclear Factor 90 Proteins
1
2021
1
0.180
Why?
RANK Ligand
1
2022
187
0.180
Why?
Ubiquitin-Protein Ligases
2
2020
96
0.180
Why?
Gene Expression Regulation
3
2022
990
0.180
Why?
Venous Thromboembolism
3
2011
77
0.180
Why?
Phenylpropionates
1
2021
13
0.180
Why?
Hippurates
1
2021
10
0.180
Why?
Gene Expression
4
2017
618
0.180
Why?
Cell Cycle
4
2010
230
0.180
Why?
Bone Neoplasms
2
2015
184
0.180
Why?
Adaptor Proteins, Signal Transducing
1
2021
202
0.170
Why?
Protease Inhibitors
3
2011
61
0.170
Why?
Receptors, G-Protein-Coupled
1
2021
56
0.170
Why?
Antigens, CD20
2
2014
6
0.170
Why?
Treatment Outcome
12
2020
5422
0.170
Why?
Cell Movement
2
2015
268
0.170
Why?
Neoplasm Metastasis
4
2015
243
0.170
Why?
Evolution, Molecular
1
2021
93
0.170
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2015
59
0.170
Why?
Time Factors
8
2021
2968
0.170
Why?
Disease-Free Survival
7
2016
460
0.170
Why?
Colorectal Neoplasms
2
2022
294
0.170
Why?
Chromosomal Instability
3
2021
16
0.170
Why?
Practice Guidelines as Topic
1
2023
488
0.170
Why?
Cytotoxicity, Immunologic
4
2015
58
0.170
Why?
Clinical Trials as Topic
1
2022
467
0.160
Why?
Tumor Suppressor Proteins
2
2019
130
0.160
Why?
Neoplasm Recurrence, Local
1
2024
649
0.160
Why?
DNA, Single-Stranded
1
2020
88
0.160
Why?
NF-E2-Related Factor 2
1
2019
47
0.160
Why?
Oncogene Proteins
1
2019
19
0.160
Why?
Mitosis
3
2015
88
0.160
Why?
Excitation Contraction Coupling
1
2018
3
0.150
Why?
Carcinoma, Neuroendocrine
1
2019
25
0.150
Why?
Transplantation, Heterologous
2
2017
79
0.150
Why?
Receptors, Interleukin-6
1
2018
23
0.150
Why?
rab GTP-Binding Proteins
1
2019
36
0.150
Why?
Cardiomegaly
1
2018
38
0.150
Why?
Healthcare Disparities
1
2022
299
0.150
Why?
Neovascularization, Pathologic
3
2009
153
0.150
Why?
Drug Tolerance
1
2018
60
0.150
Why?
Adaptation, Physiological
2
2018
110
0.150
Why?
Pyridines
1
2019
132
0.150
Why?
Blotting, Western
3
2015
590
0.150
Why?
Myocardial Contraction
1
2018
112
0.150
Why?
Ventricular Remodeling
1
2018
64
0.150
Why?
Cell Nucleus
1
2018
187
0.140
Why?
Glucaric Acid
1
2017
2
0.140
Why?
Ferric Compounds
1
2017
17
0.140
Why?
Drug Therapy, Combination
2
2017
395
0.140
Why?
Lung Neoplasms
1
2024
636
0.140
Why?
Myocytes, Cardiac
1
2018
129
0.140
Why?
beta Catenin
2
2015
102
0.140
Why?
M Phase Cell Cycle Checkpoints
1
2017
5
0.140
Why?
Mice, Knockout
4
2023
879
0.140
Why?
Hydroxamic Acids
2
2014
38
0.140
Why?
Aerobiosis
1
2017
13
0.140
Why?
Microfilament Proteins
1
2017
43
0.130
Why?
Onium Compounds
1
2016
13
0.130
Why?
Calcium-Binding Proteins
1
2017
56
0.130
Why?
Thyroid Hormones
1
2017
22
0.130
Why?
Organophosphorus Compounds
1
2016
17
0.130
Why?
Deoxyglucose
1
2016
35
0.130
Why?
Histone Deacetylase Inhibitors
2
2014
58
0.130
Why?
Survival Analysis
6
2020
673
0.130
Why?
Inhibitor of Apoptosis Proteins
3
2015
21
0.130
Why?
Gene Deletion
2
2008
272
0.130
Why?
Syndecans
3
2006
37
0.130
Why?
Pancreatic Neoplasms
1
2019
216
0.130
Why?
RNA Interference
2
2015
181
0.130
Why?
Cell Death
1
2016
177
0.130
Why?
Ribosomal Proteins
1
2016
24
0.130
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2016
45
0.130
Why?
Proto-Oncogene Proteins
2
2009
151
0.120
Why?
Proteoglycans
3
2006
87
0.120
Why?
Neoplasm Staging
4
2025
772
0.120
Why?
Muscle Proteins
1
2018
321
0.120
Why?
Oncolytic Virotherapy
1
2015
21
0.120
Why?
Macrophages
2
2022
379
0.120
Why?
Gene Dosage
2
2013
78
0.120
Why?
Cell Adhesion Molecules
1
2015
86
0.120
Why?
Calcium Channels
1
2015
42
0.120
Why?
Polysaccharides
1
2015
57
0.120
Why?
Receptors, Transferrin
1
2015
16
0.120
Why?
Core Binding Factor Alpha 1 Subunit
1
2015
47
0.120
Why?
Mitochondria, Heart
1
2015
37
0.120
Why?
Side-Population Cells
1
2015
3
0.120
Why?
Patient Selection
2
2023
259
0.120
Why?
Serine Endopeptidases
2
2006
50
0.120
Why?
Lentivirus
1
2015
17
0.120
Why?
Retinal Dehydrogenase
1
2014
10
0.120
Why?
Receptors, Cell Surface
1
2015
118
0.120
Why?
Adenine
1
2015
31
0.120
Why?
Transcription, Genetic
3
2018
378
0.120
Why?
Caspase 3
2
2022
95
0.120
Why?
Serum
1
2014
32
0.110
Why?
Cell Lineage
1
2014
85
0.110
Why?
Proto-Oncogene Proteins c-kit
1
2014
33
0.110
Why?
Superoxide Dismutase
1
2014
119
0.110
Why?
Translocation, Genetic
4
2021
265
0.110
Why?
Tumor Burden
3
2020
136
0.110
Why?
Piperidines
1
2015
97
0.110
Why?
Stress, Physiological
1
2015
183
0.110
Why?
Cyclins
3
2015
38
0.110
Why?
Alkaline Phosphatase
2
2011
94
0.110
Why?
HLA Antigens
1
2014
56
0.110
Why?
Glycoproteins
1
2014
122
0.110
Why?
Repressor Proteins
4
2015
155
0.110
Why?
11-beta-Hydroxysteroid Dehydrogenase Type 2
1
2013
12
0.110
Why?
Leukemia, Plasma Cell
1
2013
33
0.110
Why?
Lactate Dehydrogenases
1
2013
1
0.100
Why?
Phenotype
4
2009
789
0.100
Why?
Genome, Human
2
2021
121
0.100
Why?
Intercellular Adhesion Molecule-1
1
2013
61
0.100
Why?
Follow-Up Studies
5
2024
2279
0.100
Why?
Dose-Response Relationship, Drug
4
2020
1378
0.100
Why?
Scavenger Receptors, Class A
1
2013
39
0.100
Why?
Leukemia
1
2013
67
0.100
Why?
bcl-X Protein
1
2013
54
0.100
Why?
Disease Models, Animal
4
2020
1478
0.100
Why?
Heart
1
2015
345
0.100
Why?
Heat-Shock Proteins
1
2013
103
0.100
Why?
RNA, Small Interfering
2
2010
213
0.100
Why?
RNA, Neoplasm
3
2007
45
0.100
Why?
Forkhead Transcription Factors
2
2023
116
0.100
Why?
Clinical Trials, Phase III as Topic
2
2012
48
0.100
Why?
Cysteine Proteinase Inhibitors
1
2011
21
0.090
Why?
Drug Screening Assays, Antitumor
3
2020
136
0.090
Why?
Activated Protein C Resistance
1
2011
10
0.090
Why?
Factor V
1
2011
11
0.090
Why?
Protein Isoforms
2
2009
123
0.090
Why?
Acetylcysteine
1
2011
102
0.090
Why?
Glucocorticoids
1
2013
235
0.090
Why?
Interferon Regulatory Factor-1
1
2010
14
0.090
Why?
Cell Growth Processes
1
2010
22
0.090
Why?
HLA-A Antigens
2
2007
11
0.090
Why?
Cells, Cultured
6
2015
1567
0.080
Why?
Gene Silencing
2
2007
118
0.080
Why?
Alleles
2
2021
276
0.080
Why?
Mice, Inbred C57BL
3
2021
1884
0.080
Why?
Thrombosis
1
2012
253
0.080
Why?
K562 Cells
3
2016
42
0.080
Why?
Immunophenotyping
5
2010
117
0.080
Why?
Epigenesis, Genetic
2
2023
406
0.080
Why?
Microtubule-Associated Proteins
1
2009
65
0.080
Why?
Recombinant Proteins
1
2010
483
0.080
Why?
Bone Remodeling
1
2010
155
0.080
Why?
Chromosome Mapping
2
2006
154
0.080
Why?
HCT116 Cells
2
2020
30
0.080
Why?
Thromboembolism
1
2009
52
0.080
Why?
Lymphocyte Subsets
1
2008
14
0.070
Why?
Mutation
3
2021
1347
0.070
Why?
ras Proteins
2
2020
64
0.070
Why?
Angiogenesis Inhibitors
1
2009
183
0.070
Why?
Receptors, Immunologic
1
2008
39
0.070
Why?
Neoplasm Transplantation
2
2020
87
0.070
Why?
G2 Phase Cell Cycle Checkpoints
2
2020
9
0.070
Why?
Protein Tyrosine Phosphatases
1
2007
15
0.070
Why?
Adoptive Transfer
1
2007
29
0.070
Why?
Risk Assessment
3
2025
1327
0.070
Why?
Genes, abl
1
2007
2
0.070
Why?
Breast Neoplasms
2
2007
1212
0.070
Why?
Cross-Sectional Studies
2
2023
1678
0.070
Why?
HEK293 Cells
2
2019
229
0.070
Why?
Cancer Vaccines
1
2007
78
0.070
Why?
JNK Mitogen-Activated Protein Kinases
1
2007
72
0.070
Why?
Drug Evaluation, Preclinical
2
2021
146
0.070
Why?
Caspases
1
2007
104
0.070
Why?
Cyclin D
1
2006
18
0.060
Why?
Chromosome Banding
1
2006
24
0.060
Why?
Models, Genetic
1
2006
169
0.060
Why?
Proportional Hazards Models
2
2024
443
0.060
Why?
Palatine Tonsil
2
2003
11
0.060
Why?
DNA Damage
1
2008
305
0.060
Why?
Peptides
1
2007
223
0.060
Why?
Maf Transcription Factors, Large
1
2005
1
0.060
Why?
Gene Expression Regulation, Enzymologic
1
2007
179
0.060
Why?
Data Interpretation, Statistical
1
2006
164
0.060
Why?
Doxorubicin
2
2018
241
0.060
Why?
Protein Kinases
1
2005
72
0.060
Why?
Cyclin D1
1
2005
57
0.060
Why?
Antibody Formation
1
2005
51
0.060
Why?
Hydrogen Peroxide
2
2017
120
0.060
Why?
Protein Biosynthesis
2
2003
258
0.060
Why?
Neoplasm, Residual
1
2025
173
0.060
Why?
Papillomaviridae
1
2005
105
0.060
Why?
Base Sequence
3
2015
640
0.060
Why?
Cystadenocarcinoma, Serous
1
2004
73
0.060
Why?
Carcinoma, Papillary
1
2004
51
0.060
Why?
Transfection
2
2020
357
0.060
Why?
Consensus
1
2025
181
0.060
Why?
Mice, Inbred BALB C
2
2019
312
0.060
Why?
Drug Synergism
2
2014
150
0.050
Why?
Jurkat Cells
2
2014
28
0.050
Why?
Zebrafish Proteins
1
2003
23
0.050
Why?
Extracellular Matrix Proteins
1
2004
69
0.050
Why?
Adipogenesis
1
2024
49
0.050
Why?
Genetic Predisposition to Disease
1
2007
528
0.050
Why?
Glucose
2
2016
355
0.050
Why?
Ovariectomy
1
2024
113
0.050
Why?
Steroids
1
2024
59
0.050
Why?
PPAR gamma
1
2024
72
0.050
Why?
Sequence Analysis, RNA
1
2024
100
0.050
Why?
Integrin beta Chains
1
2023
14
0.050
Why?
Integrins
1
2023
31
0.050
Why?
Chromosomes, Human, Pair 13
1
2003
38
0.050
Why?
Oxidative Phosphorylation
1
2023
46
0.050
Why?
Receptors, Fibroblast Growth Factor
1
2002
8
0.050
Why?
Cytogenetic Analysis
1
2023
80
0.050
Why?
Chromosomes, Human, Pair 4
1
2002
30
0.050
Why?
Chromosomes, Human, Pair 14
1
2002
75
0.050
Why?
Macrophage Activation
1
2022
24
0.050
Why?
Oncogene Proteins, Fusion
1
2002
61
0.050
Why?
Chromosome Deletion
1
2023
142
0.050
Why?
Computational Biology
2
2020
212
0.050
Why?
Geography
1
2022
65
0.050
Why?
Porphyromonas gingivalis
1
2022
17
0.050
Why?
Chromatin
1
2023
139
0.050
Why?
Uterine Cervical Neoplasms
1
2005
299
0.050
Why?
Diploidy
3
2007
25
0.050
Why?
DNA, Neoplasm
1
2002
146
0.050
Why?
Inflammasomes
1
2022
66
0.050
Why?
Models, Animal
2
2015
234
0.050
Why?
Mutation Rate
1
2021
36
0.040
Why?
DNA Primers
2
2015
208
0.040
Why?
Clone Cells
1
2021
77
0.040
Why?
Proteins
1
2003
348
0.040
Why?
Genes, Tumor Suppressor
1
2021
74
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
69
0.040
Why?
DNA Copy Number Variations
1
2021
117
0.040
Why?
Ovarian Neoplasms
1
2004
459
0.040
Why?
Cytokines
3
2009
623
0.040
Why?
Double-Blind Method
2
2014
713
0.040
Why?
3' Untranslated Regions
1
2020
55
0.040
Why?
Wnt Signaling Pathway
1
2021
94
0.040
Why?
Immunohistochemistry
3
2009
979
0.040
Why?
Software
1
2002
280
0.040
Why?
Gene Knockout Techniques
1
2019
46
0.040
Why?
DNA
1
2023
549
0.040
Why?
Genetic Variation
1
2020
230
0.040
Why?
Crystallography, X-Ray
1
2019
156
0.040
Why?
Drug Discovery
1
2020
93
0.040
Why?
Protein Phosphatase 2
1
2019
4
0.040
Why?
Multivariate Analysis
1
2021
591
0.040
Why?
G1 Phase
1
2019
13
0.040
Why?
Enzyme Activators
1
2019
8
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
182
0.040
Why?
Protein Conformation
1
2019
176
0.040
Why?
Immunotherapy
1
2021
244
0.040
Why?
Mice, Nude
1
2019
265
0.040
Why?
Antibody-Dependent Cell Cytotoxicity
2
2009
12
0.040
Why?
Structure-Activity Relationship
1
2020
404
0.040
Why?
Active Transport, Cell Nucleus
1
2018
34
0.040
Why?
Wnt Proteins
2
2013
100
0.040
Why?
Calpain
1
2018
23
0.040
Why?
TOR Serine-Threonine Kinases
1
2019
80
0.040
Why?
Phosphorylation
1
2020
528
0.040
Why?
Drug Resistance
1
2018
65
0.040
Why?
DNA Methylation
1
2023
592
0.040
Why?
Autophagy
1
2020
193
0.040
Why?
Deferoxamine
1
2017
9
0.040
Why?
HT29 Cells
1
2017
14
0.040
Why?
Iron Chelating Agents
1
2017
12
0.040
Why?
Catalase
1
2017
73
0.030
Why?
Cell Cycle Checkpoints
1
2017
32
0.030
Why?
Cell Hypoxia
1
2016
83
0.030
Why?
Biological Transport
1
2016
160
0.030
Why?
Chronic Disease
1
2019
586
0.030
Why?
Endoplasmic Reticulum Stress
1
2016
50
0.030
Why?
Models, Statistical
2
2008
230
0.030
Why?
Drug Interactions
1
2016
206
0.030
Why?
Mice, Inbred ICR
1
2016
25
0.030
Why?
Cell Line
2
2013
1030
0.030
Why?
Transcriptional Activation
1
2016
122
0.030
Why?
Microscopy, Electron, Transmission
1
2015
78
0.030
Why?
Pharmacogenetics
2
2006
50
0.030
Why?
Vidarabine
1
2015
8
0.030
Why?
Reoviridae
1
2015
25
0.030
Why?
Mitoxantrone
1
2015
9
0.030
Why?
Myocardial Reperfusion
1
2015
9
0.030
Why?
Sarcoplasmic Reticulum
1
2015
22
0.030
Why?
Genes, Dominant
1
2015
21
0.030
Why?
Prostaglandin-Endoperoxide Synthases
1
2015
25
0.030
Why?
Antibodies, Monoclonal, Murine-Derived
1
2015
46
0.030
Why?
Diastole
1
2015
70
0.030
Why?
Vincristine
1
2015
88
0.030
Why?
Cytosol
1
2015
80
0.030
Why?
China
1
2015
134
0.030
Why?
Prednisone
1
2015
102
0.030
Why?
Cardiac Pacing, Artificial
1
2015
34
0.030
Why?
Ligands
1
2015
206
0.030
Why?
Vaccination
2
2007
298
0.030
Why?
Glutathione Peroxidase
1
2014
23
0.030
Why?
Cyclin B
1
2014
4
0.030
Why?
Microscopy, Fluorescence
1
2015
160
0.030
Why?
Molecular Targeted Therapy
1
2016
133
0.030
Why?
Disulfiram
1
2014
13
0.030
Why?
Cyclophosphamide
1
2015
171
0.030
Why?
CDC2 Protein Kinase
1
2014
16
0.030
Why?
Portraits as Topic
1
2014
2
0.030
Why?
Oxygen Consumption
1
2015
198
0.030
Why?
Membrane Potential, Mitochondrial
1
2014
39
0.030
Why?
Antigens, Differentiation, T-Lymphocyte
1
2013
11
0.030
Why?
Chemotherapy, Adjuvant
1
2014
124
0.030
Why?
Lectins, C-Type
1
2013
31
0.030
Why?
Veratrum Alkaloids
1
2013
5
0.030
Why?
Multidrug Resistance-Associated Proteins
1
2013
17
0.030
Why?
Isoxazoles
1
2013
15
0.030
Why?
Calcium
1
2015
376
0.030
Why?
G1 Phase Cell Cycle Checkpoints
1
2013
17
0.030
Why?
Electrocardiography
1
2015
268
0.030
Why?
Glutathione
1
2014
305
0.030
Why?
Hedgehog Proteins
1
2013
34
0.030
Why?
Sulfones
1
2013
25
0.030
Why?
Gene Expression Regulation, Leukemic
1
2013
32
0.030
Why?
Itraconazole
1
2013
38
0.030
Why?
Peptide Library
1
2013
16
0.030
Why?
Receptors, Glucocorticoid
1
2013
34
0.030
Why?
Receptors, IgG
1
2013
24
0.030
Why?
Oxidants
1
2013
51
0.030
Why?
Azacitidine
1
2013
39
0.030
Why?
Heart Ventricles
1
2015
267
0.030
Why?
ADP-ribosyl Cyclase
2
2003
4
0.030
Why?
p38 Mitogen-Activated Protein Kinases
1
2013
94
0.030
Why?
Hydrocortisone
1
2013
111
0.030
Why?
Epitopes
1
2013
65
0.030
Why?
MAP Kinase Signaling System
1
2013
121
0.030
Why?
Blood Pressure
1
2015
537
0.020
Why?
Histone Deacetylases
1
2013
51
0.020
Why?
Prospective Studies
2
2010
2481
0.020
Why?
Myocardium
1
2015
453
0.020
Why?
Proto-Oncogene Proteins c-bcl-2
1
2013
129
0.020
Why?
Radiation, Ionizing
1
2013
101
0.020
Why?
Osteoblasts
2
2006
475
0.020
Why?
Clinical Trials, Phase II as Topic
1
2012
47
0.020
Why?
Viper Venoms
1
2011
7
0.020
Why?
Protein C
1
2011
20
0.020
Why?
Risk
1
2011
316
0.020
Why?
Bone Density Conservation Agents
1
2010
75
0.020
Why?
Diphosphonates
1
2010
92
0.020
Why?
Databases as Topic
1
2009
39
0.020
Why?
Parathyroid Hormone
1
2010
149
0.020
Why?
Lymphocytes
1
2010
153
0.020
Why?
Cytoskeleton
1
2008
39
0.020
Why?
Genotype
1
2009
566
0.020
Why?
Twins
1
2007
33
0.020
Why?
STAT Transcription Factors
1
2007
8
0.020
Why?
Cytological Techniques
1
2007
13
0.020
Why?
NF-kappa B p52 Subunit
1
2007
6
0.020
Why?
NF-kappa B p50 Subunit
1
2007
17
0.020
Why?
I-kappa B Kinase
1
2007
20
0.020
Why?
Antibodies, Monoclonal, Humanized
1
2009
236
0.020
Why?
Karyotyping
1
2007
78
0.020
Why?
T-Lymphocytes, Cytotoxic
1
2007
66
0.020
Why?
HLA-A2 Antigen
1
2007
11
0.020
Why?
Benzamides
1
2007
50
0.020
Why?
Antigen Presentation
1
2007
26
0.020
Why?
Remission Induction
1
2007
218
0.020
Why?
Polysaccharide-Lyases
1
2007
7
0.020
Why?
Leukocytes, Mononuclear
1
2007
123
0.020
Why?
Plasmids
1
2007
163
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2007
235
0.020
Why?
Enzyme Activation
1
2007
270
0.020
Why?
Tissue Culture Techniques
1
2007
42
0.020
Why?
Interferon-gamma
1
2007
180
0.020
Why?
Multigene Family
1
2006
48
0.020
Why?
Piperazines
1
2007
118
0.020
Why?
Neoplasms, Experimental
1
2007
114
0.020
Why?
Anticoagulants
1
2009
270
0.020
Why?
Antineoplastic Agents, Hormonal
1
2006
53
0.020
Why?
Diagnosis, Differential
1
2010
1046
0.020
Why?
Dendritic Cells
1
2007
136
0.020
Why?
Polymerase Chain Reaction
1
2007
461
0.020
Why?
Receptors, Estrogen
1
2007
131
0.020
Why?
Incidence
1
2009
1062
0.020
Why?
Gelatinases
1
2006
32
0.020
Why?
Chromosomes, Human
1
2006
41
0.020
Why?
Endopeptidases
1
2006
66
0.020
Why?
Rabbits
1
2006
375
0.020
Why?
Coculture Techniques
1
2006
144
0.020
Why?
Combined Modality Therapy
1
2007
639
0.020
Why?
Cyclin D3
1
2005
5
0.010
Why?
Cyclin D2
1
2005
21
0.010
Why?
Adipocytes
1
2006
132
0.010
Why?
Trisomy
1
2005
35
0.010
Why?
Oligonucleotide Probes
1
2004
19
0.010
Why?
Stem Cells
1
2006
177
0.010
Why?
Epithelium
1
2004
65
0.010
Why?
Molecular Sequence Data
1
2006
778
0.010
Why?
Endothelium, Vascular
1
2006
246
0.010
Why?
Ovary
1
2004
107
0.010
Why?
Endothelial Cells
1
2006
262
0.010
Why?
Bacterial Proteins
1
2007
361
0.010
Why?
Databases, Factual
1
2007
706
0.010
Why?
RNA, Complementary
1
2003
2
0.010
Why?
Autocrine Communication
1
2003
7
0.010
Why?
Paracrine Communication
1
2003
12
0.010
Why?
Metaphase
1
2003
46
0.010
Why?
Receptor, Fibroblast Growth Factor, Type 3
1
2002
18
0.010
Why?
Cell Separation
1
2003
83
0.010
Why?
NAD+ Nucleosidase
1
2002
2
0.010
Why?
Melanoma-Specific Antigens
1
2002
3
0.010
Why?
Biopsy
1
2005
605
0.010
Why?
Antigens, Differentiation
1
2002
16
0.010
Why?
Cell Communication
1
2003
71
0.010
Why?
Gene Expression Regulation, Developmental
1
2003
137
0.010
Why?
Cohort Studies
1
2006
1542
0.010
Why?
Immunoglobulins
1
2002
76
0.010
Why?
Database Management Systems
1
2002
28
0.010
Why?
Reproducibility of Results
1
2005
1229
0.010
Why?
Logistic Models
1
2003
925
0.010
Why?
Magnetic Resonance Imaging
1
2003
1546
0.010
Why?
Zhan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description